Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines.

MLA

Bashiru, Mujeebat, et al. “Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines.” ACS Applied Bio Materials, vol. 7, no. 8, Aug. 2024, pp. 5359–68. EBSCOhost, https://doi.org/10.1021/acsabm.4c00552.

APA

Bashiru, M., Rayaan, M., Ali, N., Jenkins, S. V., Oyebade, A., Rahman, M. S., Griffin, R. J., Oyelere, A. K., & Siraj, N. (2024). Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines. ACS Applied Bio Materials, 7(8), 5359–5368. https://doi.org/10.1021/acsabm.4c00552

Chicago

Bashiru, Mujeebat, Muhammad Rayaan, Nawab Ali, Samir V Jenkins, Adeniyi Oyebade, Md Shahedur Rahman, Robert J Griffin, Adegboyega K Oyelere, and Noureen Siraj. 2024. “Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines.” ACS Applied Bio Materials 7 (8): 5359–68. doi:10.1021/acsabm.4c00552.